These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 21474282)
1. Pragmatic vs. explanatory: an adaptation of the PRECIS tool helps to judge the applicability of systematic reviews for daily practice. Koppenaal T; Linmans J; Knottnerus JA; Spigt M J Clin Epidemiol; 2011 Oct; 64(10):1095-101. PubMed ID: 21474282 [TBL] [Abstract][Full Text] [Related]
2. Do randomized controlled nursing trials have a pragmatic or explanatory attitude? Findings from the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) tool exercise. Palese A; Bevilacqua MG; Dante A; J Nurs Res; 2014 Sep; 22(3):216-20. PubMed ID: 25111115 [TBL] [Abstract][Full Text] [Related]
3. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems. Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976 [TBL] [Abstract][Full Text] [Related]
4. [The PRECIS-2 tool: designing trials that are fit for purpose]. Hu GP; Zhan SY Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):222-226. PubMed ID: 29495210 [TBL] [Abstract][Full Text] [Related]
5. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. Thorpe KE; Zwarenstein M; Oxman AD; Treweek S; Furberg CD; Altman DG; Tunis S; Bergel E; Harvey I; Magid DJ; Chalkidou K J Clin Epidemiol; 2009 May; 62(5):464-75. PubMed ID: 19348971 [TBL] [Abstract][Full Text] [Related]
6. PRECIS-2 for retrospective assessment of RCTs in systematic reviews. Zwarenstein M; Thorpe K; Treweek S; Loudon K J Clin Epidemiol; 2020 Oct; 126():202-206. PubMed ID: 32565215 [TBL] [Abstract][Full Text] [Related]
7. The role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review. Aves T; Allan KS; Lawson D; Nieuwlaat R; Beyene J; Mbuagbaw L BMJ Open; 2017 Sep; 7(9):e017887. PubMed ID: 28871028 [TBL] [Abstract][Full Text] [Related]
8. Use of PRECIS ratings in the National Institutes of Health (NIH) Health Care Systems Research Collaboratory. Johnson KE; Neta G; Dember LM; Coronado GD; Suls J; Chambers DA; Rundell S; Smith DH; Liu B; Taplin S; Stoney CM; Farrell MM; Glasgow RE Trials; 2016 Jan; 17():32. PubMed ID: 26772801 [TBL] [Abstract][Full Text] [Related]
9. Using the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) model in clinical research: Application to refine a practice-based research network (PBRN) study. Elder WG; Munk N J Am Board Fam Med; 2014; 27(6):846-54. PubMed ID: 25381083 [TBL] [Abstract][Full Text] [Related]
10. A comparison of meta-analytic methods for synthesizing evidence from explanatory and pragmatic trials. Sajobi TT; Li G; Awosoga O; Wang M; Menon BK; Hill MD; Thabane L Syst Rev; 2018 Jan; 7(1):19. PubMed ID: 29370830 [TBL] [Abstract][Full Text] [Related]
11. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains. Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437 [TBL] [Abstract][Full Text] [Related]
12. Pragmatic vs explanatory trials: the pragmascope tool to help measure differences in protocols of mental health randomized controlled trials. Tosh G; Soares-Weiser K; Adams CE Dialogues Clin Neurosci; 2011; 13(2):209-15. PubMed ID: 21842618 [TBL] [Abstract][Full Text] [Related]
13. Explanatory versus pragmatic trial-based economic evaluations: application to alternative therapies for burns. Carayanni V; Tsati E Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):37-48. PubMed ID: 20121563 [TBL] [Abstract][Full Text] [Related]
14. The PRECIS-2 tool has good interrater reliability and modest discriminant validity. Loudon K; Zwarenstein M; Sullivan FM; Donnan PT; Gágyor I; Hobbelen HJSM; Althabe F; Krishnan JA; Treweek S J Clin Epidemiol; 2017 Aug; 88():113-121. PubMed ID: 28603007 [TBL] [Abstract][Full Text] [Related]
15. Integrating pragmatic and implementation science randomized clinical trial approaches: a PRagmatic Explanatory Continuum Indicator Summary-2 (PRECIS-2) analysis. Zatzick D; Palinkas L; Chambers DA; Whiteside L; Moloney K; Engstrom A; Prater L; Russo J; Wang J; Abu K; Iles-Shih M; Bulger E Trials; 2023 Apr; 24(1):288. PubMed ID: 37085877 [TBL] [Abstract][Full Text] [Related]
16. The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials. Dal-Ré R Eur J Clin Pharmacol; 2021 Apr; 77(4):539-546. PubMed ID: 33106910 [TBL] [Abstract][Full Text] [Related]
18. Are trials of psychological and psychosocial interventions for schizophrenia and psychosis included in the NICE guidelines pragmatic? A systematic review. Gastaldon C; Mosler F; Toner S; Tedeschi F; Bird VJ; Barbui C; Priebe S PLoS One; 2019; 14(9):e0222891. PubMed ID: 31550279 [TBL] [Abstract][Full Text] [Related]
19. Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic? Dal-Ré R; Janiaud P; Ioannidis JPA BMC Med; 2018 Apr; 16(1):49. PubMed ID: 29615035 [TBL] [Abstract][Full Text] [Related]
20. Designing provider-focused implementation trials with purpose and intent: introducing the PRECIS-2-PS tool. Norton WE; Loudon K; Chambers DA; Zwarenstein M Implement Sci; 2021 Jan; 16(1):7. PubMed ID: 33413489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]